Tailored text message program for Smoking, Cessation

Phase-Based Progress Estimates
Smoking, Cessation
Tailored text message program - Behavioral
All Sexes
What conditions do you have?

Study Summary

This trial will test whether a smoking cessation induction intervention delivered during a dental cleaning appointment increases the utilization of evidence-based treatments (EBTs) for smoking cessation within 7 months post-dental cleaning appointment.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

3 Primary · 5 Secondary · Reporting Duration: 7 months

6 months
7-day point prevalence smoking abstinence at end-of-treatment
7 months
Motivation to quit smoking
Quit smoking attempts
Use of a combination of EBTs
Utilization of Massachusetts State Quitline
Utilization of clinic or hospital-based smoking cessation services
Utilization of the National Cancer Institute "SmokefreeTXT" service
Day 10
Participant's satisfaction

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Control group
1 of 2
Intervention group
1 of 2
Active Control
Experimental Treatment

400 Total Participants · 2 Treatment Groups

Primary Treatment: Tailored text message program · No Placebo Group · N/A

Intervention groupExperimental Group · 3 Interventions: Tailored text message program, Brochure of smoking cessation EBTs, Experimental smoking cessation video · Intervention Types: Behavioral, Other, Behavioral
Control groupActiveComparator Group · 3 Interventions: Assessment text messages, Brochure of smoking cessation EBTs, Control video · Intervention Types: Other, Other, Behavioral

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 7 months

Who is running the clinical trial?

National Institute of Dental and Craniofacial Research (NIDCR)NIH
281 Previous Clinical Trials
804,739 Total Patients Enrolled
1 Trials studying Smoking, Cessation
16 Patients Enrolled for Smoking, Cessation
Boston UniversityLead Sponsor
414 Previous Clinical Trials
10,027,566 Total Patients Enrolled
4 Trials studying Smoking, Cessation
675 Patients Enrolled for Smoking, Cessation
Belinda Borrelli, PhDPrincipal InvestigatorHenry M Goldman School of Dental Medicine
5 Previous Clinical Trials
4,745 Total Patients Enrolled
2 Trials studying Smoking, Cessation
589 Patients Enrolled for Smoking, Cessation

Eligibility Criteria

Age 18+ · All Participants · 10 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
Henry M Goldman School of Dental Medicine is a patient's upcoming dental hygiene appointment.
I smoked a cigarette in the past week.
If you responded with "never," "rarely," or "sometimes" to the question, "How often do you need to have someone help you when you read instructions, pamphlets, or other written material from your doctor, dentist, or pharmacy?" on the validated single-item literacy screener, you are likely to have low literacy skills.
in both English and Spanish She can understand written and spoken study materials in both English and Spanish.
Some people said that they are able to wear headphones that are inserted partially inside the ear
by youth was high Around three-quarters of youth reported using text messaging at least once in the month before the survey.
In order to have access to necessary resources for intervention, a cell phone capable of text messaging is required
I have smoked 100 cigarettes or more in my lifetime.
Some people reported smoking cigarettes every day in the preceding week.
You have no difficulty with your vision, even when wearing glasses.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 11th, 2021

Last Reviewed: October 6th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.